Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents

Biochemical and Biophysical Research Communications

Volumn 381, Issue 4, 2009, Pages 643-648

  Gonzalez, Ronald ^a   Tiwari, Akansha ^a   Unniappan, Suraj ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

Alpha cells; Beta cells; Glucagon; Immunoreactivity; Insulin; Islets; Nesfatin; NUCB2; Pancreas

Indexed keywords

GLUCAGON; INSULIN; PRONESFATIN; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FISCHER 344 RAT; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED STRAINS; RATS; RATS, INBRED F344;

MUS; RATTUS; RODENTIA;

EID: 62649109918     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.104     Document Type: Article

References (18)

1. Oh-I S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimot K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., and Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443 (2006) 709-712
2. Myers Jr. M.G. Keeping the fat off with nesfatin. Nat. Med. 12 (2006) 1248-1249
3. Cowley M.A., and Grove K.L. To be or NUCB2, is nesfatin the answer?. Cell Metab. 4 (2006) 421-422
4. Shimizu H., Oh-I S., Hashimoto K., Nakata M., Yamamoto S., Yoshida N., Eguchi H., Kato I., Inoue K., Satoh T., Okada S., Yamada M., Yada T., and Mori M. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150 (2009) 662-671
5. Brailoiu G.C., Dun S.L., Brailoiu E., Inan S., Yang J., Chang J.K., and Dun N.J. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148 (2007) 5088-5094
6. Kohno D., Nakata M., Maejima Y., Shimizu H., Sedbazar U., Yoshida N., Dezaki K., Onaka T., Mori M., and Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 149 (2008) 1295-1301
7. Fort P., Salvert D., Hanriot L., Jego S., Shimizu H., Hashimoto K., Mori M., and Luppi P.H. The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience 155 (2008) 174-181
8. Nonogaki K., Ohba Y., Sumii M., and Oka Y. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice. Biochem. Biophys. Res. Comm. 372 (2008) 186-190
9. Foo K., Brismar H., and Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 156 (2008) 563-579
10. Iguchi H., Ikeda Y., Okamura M M., Tanaka T., Urashima Y., Ohguchi H., Takayasu S., Kojima N., Iwasaki S., Ohashi R., Jiang S., Hasegawa G., Ioka R.X., Magoori K., Sumi K., Maejima T., Uchida A., Naito M., Osborne T.F., Yanagisawa M., Yamamoto T.T., Kodama T., and Sakai J. SOX6 attenuates glucose-stimulated insulin secretion by repressing PDX1 transcriptional activity and is down-regulated in hyperinsulinemic obese mice. J. Biol. Chem. 280 (2005) 37669-37680
11. Stengel A., Goebel M., Yakubov I., Wang L., Witcher D., Coskun T., Taché Y., Sachs G., and Lambrecht N.W. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150 (2009) 232-238
12. Zhu X., Orci L., Carroll R., Norrbom R., Ravazzola M., and Steiner D.F. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64, 65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc. Natl. Acad. Sci. USA 99 (2002) 10299-10304
13. Marcinkiewicz M., Ramla D., Seidah N.G., and Chretien M. Developmental expression of the prohormone convertases PC1 and PC2 in mouse pancreatic islets. Endocrinology 135 (1994) 1651-1660
14. Furuta M., Yano H., Zhou A., Rouille Y., Holst J.J., Carroll R., Ravazzola M., Orci L., Furuta H., and Steiner D.F. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc. Natl. Acad. Sci. USA 94 (1997) 6646-6651
15. Rouillé Y., Duguay S.J., Lund K., Furuta M., Gong Q., Lipkind G., Oliva Jr. A.A., Chan S.J., and Steiner D.F. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front. Neuroendocrinol. 16 (1995) 322-361
16. Lee Y.C., Damholt A.B., Billestrup N., Kisbye T., Galante P., Michelsen B., Kofod H., and Nielsen J.H. Developmental expression of proprotein convertase 1/3 in the rat. Mol. Cell. Endocrinol. 155 (1999) 27-35
17. Neerman-Arbez M., Cirulli V., and Halban P.A. Levels of the conversion endoproteases PC1 (PC3) and PC2 distinguish between insulin-producing pancreatic islet beta cells and non-beta cells. Biochem. J. 300 (1994) 57-61
18. Merali Z., Cayer C., Kent P., and Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl.) 201 (2008) 115-123